Zimmer Biomet Holdings, Inc. logo
Zimmer Biomet Holdings, Inc. (ZBH)
Compare

ZBH Dividends

Zimmer Biomet Holdings, Inc. (ZBH) pays $0.96 in dividends per share, with a current dividend yield of 1.09%.

ZBH Dividend Summary

Consecutive Years

0

Next Ex-Dividend Date

Jun 25, 2026

Next Payment Date

Jul 31, 2026

ZBH Dividends per Share (Nominal History)

View full nominal table list

This step chart displays the nominal dividend payouts over time on their actual payment dates, matching the distribution frequency.

ZBH Dividends CAGR Chart

Zimmer Biomet Holdings, Inc. (ZBH)

Annual Dividend History

YearDividend/ShareYoY Growth
2026(YTD)$0.48
2025$0.96+0.00%
2024$0.96+0.00%
2023$0.96+0.00%
2022$0.96+3.00%
2021$0.93+0.00%
2020$0.93+0.00%
2019$0.93+0.00%
2018$0.93+0.00%
2017$0.93+0.00%
2016$0.93+9.09%
2015$0.85+0.00%
2014$0.85+10.00%
2013$0.78+11.11%
2012$0.70N/A

Quarterly Dividend History

QuarterDividend/ShareYoY Growth
Q2 2026$0.24+0.00%
Q1 2026$0.24+0.00%
Q4 2025$0.24+0.00%
Q3 2025$0.24+0.00%
Q2 2025$0.24+0.00%
Q1 2025$0.24+0.00%
Q4 2024$0.24+0.00%
Q3 2024$0.24+0.00%
Q2 2024$0.24+0.00%
Q1 2024$0.24+0.00%
Q4 2023$0.24+0.00%
Q3 2023$0.24+0.00%
Q2 2023$0.24+0.00%
Q1 2023$0.24+0.00%
Q4 2022$0.24+3.00%
Q3 2022$0.24+3.00%
Q2 2022$0.24+3.00%
Q1 2022$0.24+3.00%
Q4 2021$0.23+0.00%
Q3 2021$0.23+0.00%
Q2 2021$0.23+0.00%
Q1 2021$0.23+0.00%
Q4 2020$0.23+0.00%
Q3 2020$0.23+0.00%

Dividend Yield Metrics

Current Yield
1.09%
Average Yield (TTM)
1.09%
Average Yield (3Y)
1.09%
Forward Yield on Cost (3Y)
1.12%
Forward Yield on Cost (5Y)
1.15%
Forward Yield on Cost (10Y)
1.20%

Payout Ratio Analysis

Payout Ratio (Current)
24.94%
FCF Payout Ratio
10.36%
Payout Ratio (3Y Avg)
22.70%
Payout Ratio (5Y Avg)
40.73%
FCF Payout (3Y Avg)
15.62%
FCF Payout (5Y Avg)
16.03%

Dividend Coverage

Payout Ratio
24.9%
Dividends / net income
FCF Payout Ratio
10.4%
Dividends / free cash flow
Consecutive Years
N/A
Years with regular dividend payments
5Y Dividend Growth
0.6%
Compound annual dividend growth

About Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. (ZBH), along with its global subsidiaries, operates as a leading player in the musculoskeletal healthcare sector. The company extends its reach across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. ZBH is responsible for the design, manufacturing, and marketing of a wide array of orthopedic reconstructive solutions, including prominent knee and hip replacement systems. Their offerings also encompass Specialized Enabling Technologies (S.E.T.) products, which cover areas such as sports medicine, biologics, foot and ankle care, extremity treatments, and trauma management. Furthermore, the company provides medical devices and surgical instruments specifically for spinal conditions, alongside products for facial and cranial reconstruction. A unique part of their portfolio includes systems designed to stabilize and fixate chest bones, facilitating recovery or reconstruction following open-heart surgery, traumatic injuries, or congenital chest deformities. The company's product lines also feature a comprehensive range of dental solutions, such as reconstructive implants, prosthetics, and regenerative materials. Additionally, they are involved in robotic surgical systems, general surgical instruments, and bone cements. These advanced products and solutions are primarily utilized to address conditions in patients suffering from disorders or injuries affecting bones, joints, and their associated soft tissues. Zimmer Biomet caters to a broad clientele, including orthopedic, neuro-, and oral surgeons, dentists, hospitals, independent distributors, healthcare suppliers, and various other medical specialists. Their network further encompasses agents, healthcare purchasing organizations, and group buying alliances. Originally established in 1927, the enterprise was initially known as Zimmer Holdings, Inc., before rebranding as Zimmer Biomet Holdings, Inc. in June 2015. Its corporate headquarters are situated in Warsaw, Indiana.

Warsaw, IN
17,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ivan Tornos